Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mitesco (MITI) EPS (Weighted Average and Diluted) (2011 - 2026)

Mitesco (MITI) reported EPS (Weighted Average and Diluted) of -$0.05 for Q1 2026, up 37.5% year-over-year from -$0.04 in Q1 2025, and down 183.33% on a QoQ basis from $0.06 in Q4 2025.

Mitesco (MITI) has 11 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.05 in Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 37.5% year-over-year to -$0.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.27 (up 42.55% YoY) and the FY2025 annual result came in at -$0.14, up 66.67% from the prior year.
  • EPS (Weighted Average and Diluted) retreated to -$0.05 in Q1 2026 per MITI's latest filing, from $0.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.29 in Q3 2024 and bottomed at -$5.77 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.13 (2024), against an average of -$0.63.
  • The widest annual swing landed in 2024, when EPS (Weighted Average and Diluted) soared 170.73%; it then slumped 193.1% in 2025.
  • Tracing MITI's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.59 in 2022, then sank by 877.97% to -$5.77 in 2023, then surged by 90.81% to -$0.53 in 2024, then jumped by 111.32% to $0.06 in 2025, then sank by 183.33% to -$0.05 in 2026.
  • Per Business Quant, the three latest MITI EPS (Weighted Average and Diluted) figures stand at -$0.05 (Q1 2026), $0.06 (Q4 2025), and -$0.27 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.48
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.67
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.82
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.41
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.10
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.22
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -0.10
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.02
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.25
10 Mitesco - - - -0.05

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.05
Dec 31, 2025 0.06
Sep 30, 2025 -0.27
Jun 30, 2025 -0.01
Mar 31, 2025 -0.08
Dec 31, 2024 -0.53
Sep 30, 2024 0.29
Jun 30, 2024 -0.15
Mar 31, 2024 -0.11
Dec 31, 2023 -5.43
Sep 30, 2023 -0.48
Sep 30, 2022 -0.59
Mar 31, 2020 0.00
Sep 30, 2019 -0.03
Jun 30, 2019 -0.01
Mar 31, 2019 -0.02
Dec 31, 2018 -0.02
Sep 30, 2018 -0.02
Jun 30, 2018 -0.01
Mar 31, 2018 0.00
Dec 31, 2017 -0.01
Sep 30, 2017 -0.01
Jun 30, 2017 -0.02
Mar 31, 2017 -0.01
Dec 31, 2016 0.05
Sep 30, 2016 -0.17
Jun 30, 2016 -0.15
Sep 30, 2011 0.00